Search filters

List of works by Michael J. Morris

(11)C-acetate PET imaging in prostate cancer

scientific article published on 01 February 2007

A Clinical Evaluation of Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer: Guiding Principles for Treatment Selection and Perspectives on Research

scientific article published on 29 December 2020

A Molecular Model for Predicting Overall Survival in Patients with Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance).

scientific article published on 8 September 2015

A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer

scientific article

A Pilot Study of a Multimodal Treatment Paradigm to Accelerate Drug Evaluations in Early-stage Metastatic Prostate Cancer.

scientific article published on 22 November 2016

A Preanalytic Validation Study of Automated Bone Scan Index: Effect on Accuracy and Reproducibility Due to the Procedural Variabilities in Bone Scan Image Acquisition.

scientific article published on 21 July 2016

A case report of putative autoimmunity to prostate cancer after immune-mediated rejection of melanoma through a shared tumor antigen

scientific article published on 27 January 2012

A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancer.

scientific article

A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index.

scientific article

A phase 2 trial of abiraterone acetate without glucocorticoids for men with metastatic castration-resistant prostate cancer

scientific article published on 14 November 2018

A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumors.

scientific article

A phase I/IIA study of AGS-PSCA for castration-resistant prostate cancer ⬇️

scientific article published on May 2, 2012

A phase II trial of bortezomib and prednisone for castration resistant metastatic prostate cancer

scientific article published on 22 October 2007

A polyvalent vaccine for high-risk prostate patients: "are more antigens better?"

scientific article published on 10 July 2007

Analytic Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer

scientific article published on 27 August 2015

Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC)

scientific article published on 03 May 2019

Androgen deprivation and thromboembolic events in men with prostate cancer.

scientific article published on 9 November 2011

Androgen deprivation for minimal metastatic disease: threshold for achieving undetectable prostate-specific antigen

scientific article published on 01 May 2005

Antibody mass escalation study in patients with castration-resistant prostate cancer using 111In-J591: lesion detectability and dosimetric projections for 90Y radioimmunotherapy

scientific article published on 13 June 2008

Assessing outcomes in prostate cancer clinical trials: a twenty-first century tower of Babel

scientific article published on September 2008

Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC).

scientific article published on 16 September 2014

Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide

scientific article published on 9 March 2016

Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration-resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance).

scientific article

Bone metastases in castration-resistant prostate cancer: associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival

scientific article

Bone scan index: a quantitative treatment response biomarker for castration-resistant metastatic prostate cancer.

scientific article published on 9 January 2012

Brain Metastases from Prostate Cancer: An 11‐Year Analysis in the MRI Era with Emphasis on Imaging Characteristics, Incidence, and Prognosis ⬇️

scientific article published on December 28, 2012

Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial.

scientific article

Castration resistant, taxane naïve metastatic prostate cancer: current clinical approaches and future directions

scientific article published on 20 July 2007

Clinical approaches to osseous metastases in prostate cancer.

scientific article

Clinical experience with intravenous estramustine phosphate, paclitaxel, and carboplatin in patients with castrate, metastatic prostate adenocarcinoma

scientific article published in November 2003

Comparison of Magnetic Resonance Imaging-stratified Clinical Pathways and Systematic Transrectal Ultrasound-guided Biopsy Pathway for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis of Randomized Contro

scientific article published on 14 June 2019

Computer-aided quantitative bone scan assessment of prostate cancer treatment response.

scientific article published on April 2012

Department of Defense prostate cancer clinical trials consortium: a new instrument for prostate cancer clinical research.

scientific article

Developing imaging strategies for castration resistant prostate cancer

scientific article

Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer

scientific article published on 29 September 2020

Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial

scientific article published on 8 November 2013

Dynamic change in phosphorylated platelet-derived growth factor receptor in peripheral blood leukocytes following docetaxel therapy predicts progression-free and overall survival in prostate cancer.

scientific article published on 07 October 2008

Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy

scientific article

Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group

scientific article

End points and outcomes in castration-resistant prostate cancer: from clinical trials to clinical practice

scientific article published on 22 August 2011

Evaluation of Castration-Resistant Prostate Cancer with Androgen Receptor-Axis Imaging.

scientific article

Everolimus combined with gefitinib in patients with metastatic castration-resistant prostate cancer: Phase 1/2 results and signaling pathway implications.

scientific article

Expression of prostate-specific membrane antigen in renal cortical tumors.

scientific article published on 14 March 2008

Failure of ELM-PC 5: an ineffective drug or an unfit end point?

scientific article published on 02 February 2015

First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake.

scientific article published on 11 August 2016

Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer

scientific article published in June 2002

Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy.

scientific article

Fully automated synthesis of [(18) F]fluoro-dihydrotestosterone ([(18) F]FDHT) using the FlexLab module.

scientific article published on 4 July 2016

Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer

scientific article published on 14 July 2011

Germline BRCA mutations denote a clinicopathologic subset of prostate cancer

scientific article published on 09 March 2010

HER-2 profiling and targeting in prostate carcinoma

scientific article published on 01 February 2002

Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer

scientific article

High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma

scientific article published in May 2004

Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancer

scientific article published on 24 February 2020

Impact of therapy on genomics and transcriptomics in high-risk prostate cancer treated with neoadjuvant docetaxel and androgen deprivation therapy.

scientific article published on 25 August 2017

Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumors.

scientific article published on 29 April 2015

Innovations and Challenges in Prostate Cancer: Summary Statement for the 6th Cambridge Conference

article

Integrative Clinical Genomics of Advanced Prostate Cancer

scientific article

Integrative clinical genomics of advanced prostate cancer

scientific article

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

scientific article published on 27 January 2020

Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.

scientific article

Management of recurrent prostate cancer after radiotherapy: long-term results from CALGB 9687 (Alliance), a prospective multi-institutional salvage prostatectomy series

scientific article published on 01 November 2018

Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trials

scientific article published on 29 April 2019

Meeting Report From the Prostate Cancer Foundation Scientific Working Group on Radium-223.

scientific article published on November 2016

Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting

scientific article published on 31 August 2020

Men's Eating and Living (MEAL) study (CALGB 70807 [Alliance]): recruitment feasibility and baseline demographics of a randomized trial of diet in men on active surveillance for prostate cancer.

scientific article published on 24 April 2017

Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer

scientific article

Methylphenidate for fatigue in ambulatory men with prostate cancer

scientific article

Molecular Imaging and Targeted Radionuclide Therapy of Prostate Cancer

scientific article published on 01 October 2016

Monitoring the Clinical Outcomes in Advanced Prostate Cancer: What Imaging Modalities and Other Markers Are Reliable? ⬇️

scientific article published on June 1, 2013

Optimizing targeted therapy and developing novel outcome measures for patients with advanced prostate cancer at Memorial Sloan-Kettering Cancer Center.

scientific article

Organoid cultures derived from patients with advanced prostate cancer

scientific article

Paclitaxel and carboplatin versus mitoxantrone: lessons of an underpowered study

scientific article published on 01 October 2006

Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy

scientific article published on 3 May 2016

Pharmacokinetic assessment of the uptake of 16beta-18F-fluoro-5alpha-dihydrotestosterone (FDHT) in prostate tumors as measured by PET.

scientific article

Pharmacokinetics and Biodistribution of a [89Zr]Zr-DFO-MSTP2109A Anti-STEAP1 Antibody in Metastatic Castration-Resistant Prostate Cancer Patients

scientific article published on 31 May 2019

Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer.

scientific article

Phase I dose-escalation study of the novel antiandrogen BMS-641988 in patients with castration-resistant prostate cancer

scientific article

Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumors.

scientific article published on May 2007

Phase I pharmacokinetic and biodistribution study with escalating doses of ²²³Ra-dichloride in men with castration-resistant metastatic prostate cancer.

scientific article

Phase II trial of docetaxel with rapid androgen cycling for progressive noncastrate prostate cancer

scientific article

Phase Ib Study of Enzalutamide in Combination with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer.

scientific article

Pilot study of epothilone B analog (BMS-247550) and estramustine phosphate in patients with progressive metastatic prostate cancer following castration

scientific article published in October 2003

Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancer.

scientific article published on October 2005

Platelet-derived growth factor receptor inhibition and chemotherapy for castration-resistant prostate cancer with bone metastases

scientific article published in October 2007

Post-therapy changes in PSA as an outcome measure in prostate cancer clinical trials.

scientific article published on December 2006

Practical approach for comparative analysis of multilesion molecular imaging using a semiautomated program for PET/CT

scientific article

Prevalence of pain and analgesic use in men with metastatic prostate cancer using a patient-reported outcome measure.

scientific article published on 25 June 2013

Prognostic value of baseline [18F] fluorodeoxyglucose positron emission tomography and 99mTc-MDP bone scan in progressing metastatic prostate cancer

scientific article

Prostate cancer clinical trial end points: "RECIST"ing a step backwards.

scientific article published on July 2005

Prostate-Specific Membrane Antigen-Directed Therapy for Metastatic Castration-Resistant Prostate Cancer

scientific article

Quantification of bone flare on F-NaF PET/CT in metastatic castration-resistant prostate cancer

scientific article published on 09 November 2018

Quantitative Assessment of Early [18F]Sodium Fluoride Positron Emission Tomography/Computed Tomography Response to Treatment in Men With Metastatic Prostate Cancer to Bone.

scientific article published on 27 June 2017

Radiation safety considerations for the use of ²²³RaCl₂ DE in men with castration-resistant prostate cancer

scientific article published on April 2014

Radiographic progression-free survival as a response biomarker in metastatic castration-resistant prostate cancer: COU-AA-302 results

scientific article

Radium-223 mechanism of action: implications for use in treatment combinations

scientific article published on 11 November 2019

Radium-223 outcomes after multiple lines of metastatic castration-resistant prostate cancer therapy in clinical practice: implication of pre-treatment spinal epidural disease.

scientific article

Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401.

scientific article

Rapid androgen cycling as treatment for patients with prostate cancer.

scientific article

Repeatability of Quantitative 18F-NaF PET: A Multicenter Study.

scientific article

Repetitively dosed docetaxel and ¹⁵³samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer.

scientific article

Reply to B. Rini et al and S. Buti et al.

scientific article

Reply to K. Lu

scientific article published on 27 July 2015

Reproducibility and clinical correlations of post-treatment changes on CT of prostate cancer bone metastases treated with chemotherapy.

scientific article

Response

Safety and biologic activity of intravenous BCL-2 antisense oligonucleotide (G3139) and taxane chemotherapy in patients with advanced cancer

scientific article

Severe Hypocalcemia Associated With Denosumab in Metastatic Castration-Resistant Prostate Cancer: Risk Factors and Precautions for Treating Physicians.

scientific article published on 22 November 2014

Simultaneous quantitation of abiraterone, enzalutamide, N-desmethyl enzalutamide, and bicalutamide in human plasma by LC-MS/MS.

scientific article published on 13 February 2017

Targeting the androgen receptor in prostate and breast cancer: several new agents in development

scientific article

Therapeutic Implications of Germline Testing in Patients With Advanced Cancers

scientific article published on 16 June 2021

Therapeutic Strategies for Bone Metastases and Their Clinical Sequelae in Prostate Cancer ⬇️

scientific article published on June 1, 2012

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

scientific article

Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer.

scientific article published on 21 January 2014

Validation and clinical utility of prostate cancer biomarkers.

scientific article published on 05 March 2013

When Progressive Disease Does Not Mean Treatment Failure: Reconsidering the Criteria for Progression ⬇️

scientific article published on August 27, 2012

⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer

scientific article

Paulina is supported by:

About Paulina

Help